Eagle Bay Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,489
Closed -$120K 627
2024
Q4
$120K Sell
1,489
-111
-7% -$9.61K 0.08% 174
2024
Q3
$145K Sell
1,600
-14
-0.9% -$1.18K 0.06% 219
2024
Q2
$128K Buy
1,614
+958
+146% +$78.5K 0.08% 176
2024
Q1
$57.6K Buy
656
+101
+18% +$8.62K 0.04% 286
2023
Q4
$45.7K Sell
555
-964
-63% -$73.5K 0.03% 307
2023
Q3
$119K Buy
1,519
+43
+3% +$3.6K 0.06% 219
2023
Q2
$130K Sell
1,476
-88
-6% -$7.58K 0.07% 169
2023
Q1
$126K Buy
1,564
+348
+29% +$28.4K 0.07% 189
2022
Q4
$94.5K Buy
1,216
+109
+10% +$8.83K 0.05% 250
2022
Q3
$90K Sell
1,107
-908
-45% -$81.6K 0.06% 223
2022
Q2
$181K Buy
+2,015
New +$204K 0.11% 129
2022
Q1
Sell
-1,557
Closed -$167K 681
2021
Q4
$167K Sell
1,557
-694
-31% -$80.4K 0.11% 125
2021
Q3
$283K Buy
2,251
+762
+51% +$98.6K 0.16% 95
2021
Q2
$190K Buy
+1,489
New +$187K 0.15% 91

Other funds holding MDT

Eagle Bay Advisors's MDT Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Medtronic (MDT) in Q1 2025, closing a stake of 1,489 shares — an estimated $120K sold.

Eagle Bay Advisors first reported a position in MDT in Q2 2021 and held it in 14 quarters. The position peaked at $283K in Q3 2021. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 1,489 Medtronic shares in Q1 2025, an estimated $120K.
  • Eagle Bay Advisors first reported a position in Medtronic in Q2 2021 and held it in 14 quarters.
  • Eagle Bay Advisors's Medtronic position peaked at $283K in Q3 2021.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.